Capstar Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Gelesisgelesis.cominAug 2022SEC filingmedium confidence
Gelesis develops biomimicry-based, nature-inspired therapeutics aimed at addressing unmet medical needs and major health challenges.
BiotechHealthtechBoston, US
Meghan Fitzgerald(Director)John LaMattina(Director)Robert Forrester(Director)Yishai Zohar(Director, President, and Chief Executive Officer)Elliot Maltz(Treasurer)
BoardElon Boms(Director)
Board seatKathryn Cavanaugh· per SEC Form D · $50.6M raise · filed Aug 2022
Underscore USA, Inc.Aug 2022SEC filingmedium confidence
New York, US
Board seatKathryn Cavanaugh· per SEC Form D · $10.4M raise · filed Aug 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.